If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 221 - 230 of 306
Stimulating the Aging Brain (StAB): Noninvasive Brain and Sensory Stimulation Strategies in Aging
Objective
Stimulating the Aging Brain (StAB)
Protocol No
NEURO-IIT-SHAH-STAB
A Phase 1b/2, Open-Label, Master Protocol Study of BTK-Degrader BGB-16673 in Combination with Other Agents in Patients with Relapsed or Refractory B-Cell Malignancies
Objective
Study of BGB-16673 in combination with other agents for patients with R/R B-cell malignancies
Protocol No
BEIGENE-BGB-16673-104
Categories
A Phase 2, Single-Arm Study of INCB123667 in Participants with Platinum-Resistant Ovarian Cancer with Cyclin E1 Overexpression
Objective
In this project we want to find out more about an investigational drug, INCB123667, and how it works for people living with platinum-resistant ovarian cancer with cyclin E1.
Protocol No
GOG-3129-INCYTE-INCB123667-203
Categories
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Objective
SetPoint System as a Pro-Remyelination Therapy for Relapsing MS
Protocol No
NEURO-SETPOINT-SPM-040
Use of Quercetin to Increase Resiliency to Palmitic Acid in the Human Microvasculature
Objective
Palmitic Acid and Human Microvascular Function
Protocol No
ANES-IIT-FREED-PALM
Categories
A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
Objective
A Phase 2 Study of Inobrodib in Combination with Pomalidomide and Dexamethasone in Patients with R/R MM
Protocol No
CELLCENTRIC-CCS1477-04
Categories
A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, Followed by Open-label Treatment W
Objective
Efficacy of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing MS
Protocol No
NEURO-NOVARTIS-RESHAPE
A Randomized Phase III Study Comparing Temporally-Modulated Pulsed Radiation Therapy (TMPRT) Versus Standard Radiation Therapy With Temozolomide for Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma
Objective
A Phase III Randomized Study Comparing Temporally-Modulated Pulsed RT Vs Std RT for the Tx of Patients W/MGMT Unmethylated Glioblastoma
Protocol No
NRG-CC017
Categories
BAF_FRontier-01, A First-in-Human, Phase 1a/1b Trial to Assess Safety, Tolerability, and Preliminary Efficacy of LY4152199, a B-Cell Activation Factor Receptor (BAFF-R) T-Cell Engager Bispecific Antibody, in Adult Participants with Previously Treated
Objective
A Phase 1a/1b Study of LY4152199 in Patients with Previously Treated B-cell Malignancies
Protocol No
LILLY-J6N-MC-JUCA
Categories
A First-in-Human, Multicenter Phase 1a/1b Study to Investigate Safety, Tolerability, Pharmacokinetics, and Efficacy of LY4584180 in Adult Participants with Previously Treated Hematologic Malignancies
Objective
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Efficacy of LY4584180 in Adult Participants with Previously Treated Hematologic Malignancies
Protocol No
LILLY-J6Y-OX-JBFA
Categories